Form 4 filed by Moat Ross
Moat Ross filed this Form 4 on KNSA (Kiniksa Pharmaceuticals International, plc) with 29 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-03 23:27:21 UTC.
- Accession
- 0001857177-26-000010
- Filer
- CIK 1857177
- Filed
- 2026-11-03
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: KNSA · Kiniksa Pharmaceuticals International, plc (CIK 1730430)
- Moat Ross officer (CHIEF OPERATING OFFICER)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Class A Ordinary Share | 2026-10-30 | M exercised | +16,111 | $10.76 | 32,418 | D |
| Class A Ordinary Share | 2026-10-30 | M exercised | +21,059 | $11.1 | 53,477 | D |
| Class A Ordinary Share | 2026-10-30 | M exercised | +3,760 | $11.97 | 57,237 | D |
| Class A Ordinary Share | 2026-10-30 | M exercised | +1,658 | $12.97 | 58,895 | D |
| Class A Ordinary Share | 2026-10-30 | M exercised | +16,112 | $17.76 | 75,007 | D |
| Class A Ordinary Share | 2026-10-30 | M exercised | +10,895 | $18.06 | 85,902 | D |
| Class A Ordinary Share | 2026-10-30 | S sold | -37,775 | $92 | 48,127 | D |
| Class A Ordinary Share | 2026-10-30 | S sold | -15,114 | $92.81 | 33,013 | D |
| Class A Ordinary Share | 2026-10-30 | S sold | -8,430 | $93.97 | 24,583 | D |
| Class A Ordinary Share | 2026-10-30 | S sold | -6,282 | $94.92 | 18,301 | D |
| Class A Ordinary Share | 2026-10-30 | S sold | -3,672 | $96.03 | 14,629 | D |
| Class A Ordinary Share | 2026-10-30 | S sold | -1,760 | $97.1 | 12,869 | D |
| Class A Ordinary Share | 2026-10-30 | S sold | -2,575 | $97.76 | 10,294 | D |
| Class A Ordinary Share | 2026-11-02 | M exercised | +9,412 | $18.06 | 19,706 | D |
| Class A Ordinary Share | 2026-11-02 | M exercised | +12,302 | $21.77 | 32,008 | D |
| Class A Ordinary Share | 2026-11-02 | M exercised | +6,263 | $22.89 | 38,271 | D |
| Class A Ordinary Share | 2026-11-02 | S sold | -6,681 | $91.23 | 31,590 | D |
| Class A Ordinary Share | 2026-11-02 | S sold | -8,932 | $92.05 | 22,658 | D |
| Class A Ordinary Share | 2026-11-02 | S sold | -11,642 | $93.15 | 11,016 | D |
| Class A Ordinary Share | 2026-11-02 | S sold | -722 | $94.05 | 10,294 | D |
| Share Option derivative | 2026-10-30 | M exercised | -16,111 | $0 | 7,250 | D |
| Share Option derivative | 2026-10-30 | M exercised | -21,059 | $0 | 0 | D |
| Share Option derivative | 2026-10-30 | M exercised | -3,760 | $0 | 23,492 | D |
| Share Option derivative | 2026-10-30 | M exercised | -1,658 | $0 | 0 | D |
| Share Option derivative | 2026-10-30 | M exercised | -16,112 | $0 | 11,277 | D |
| Share Option derivative | 2026-10-30 | M exercised | -10,895 | $0 | 25,205 | D |
| Share Option derivative | 2026-11-02 | M exercised | -9,412 | $0 | 15,793 | D |
| Share Option derivative | 2026-11-02 | M exercised | -12,302 | $0 | 27,062 | D |
| Share Option derivative | 2026-11-02 | M exercised | -6,263 | $0 | 1,691 | D |